These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21925003)

  • 1. Infection and infection prevention in patients treated with immunosuppressive medications for autoimmune bullous disorders.
    Lehman JS; Murrell DF; Camilleri MJ; Kalaaji AN
    Dermatol Clin; 2011 Oct; 29(4):591-8. PubMed ID: 21925003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Vaccination of children and adults with autoimmune diseases].
    Zink A
    Z Rheumatol; 2007 Mar; 66(2):101. PubMed ID: 17294059
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug damage and infectious diseases (report) (author's transl)].
    Gsell OR
    Verh Dtsch Ges Pathol; 1972; 56():88-98. PubMed ID: 4130919
    [No Abstract]   [Full Text] [Related]  

  • 4. Autoimmune bullous diseases in Austria.
    Laimer M; Pohla-Gubo G; Kraus L; Nischler E; Bauer JW; Ahlgrimm-Siess V; Hintner H
    Dermatol Clin; 2011 Oct; 29(4):691-8. PubMed ID: 21925021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Pneumocystis carinii pneumonia in patients with immunobullous and connective tissue disease receiving immunosuppressive medications.
    Gerhart JL; Kalaaji AN
    J Am Acad Dermatol; 2010 Jun; 62(6):957-61. PubMed ID: 19828210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Literature-based immunization recommendations for patients requiring immunosuppressive medications for autoimmune bullous dermatoses.
    Laniosz V; Lehman JS; Poland GA; Wetter DA
    Int J Dermatol; 2016 Jun; 55(6):599-607. PubMed ID: 26711431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of infections with biological agents.
    Kopylov U; Afif W
    Gastroenterol Clin North Am; 2014 Sep; 43(3):509-24. PubMed ID: 25110256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence-based guidelines for laboratory screening for infectious diseases before initiation of systemic immunosuppressive agents in patients with autoimmune bullous dermatoses.
    Keith PJ; Wetter DA; Wilson JW; Lehman JS
    Br J Dermatol; 2014 Dec; 171(6):1307-17. PubMed ID: 25130049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune blistering diseases: incidence and treatment in Croatia.
    Marinovic B; Lipozencic J; Jukic IL
    Dermatol Clin; 2011 Oct; 29(4):677-9. PubMed ID: 21925017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of acquired bullous skin diseases.
    Fine JD
    N Engl J Med; 1995 Nov; 333(22):1475-84. PubMed ID: 7477149
    [No Abstract]   [Full Text] [Related]  

  • 11. [Side effects in immunosuppressive therapy].
    Thumb N
    Acta Med Austriaca; 1975; 2(4):134-40. PubMed ID: 1243805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticipating and preventing infection in patients treated with immunosuppressive medications for dermatologic indications: a dermatologist's checklist.
    Lehman JS; Wetter DA; Davis MD; el-Azhary RA; Gibson LE; Kalaaji AN
    J Am Acad Dermatol; 2014 Oct; 71(4):e125-6. PubMed ID: 25219725
    [No Abstract]   [Full Text] [Related]  

  • 13. Research in practice: Treatment of autoimmune bullous disorders.
    Hertl M
    J Dtsch Dermatol Ges; 2009 Jun; 7(6):500-5. PubMed ID: 19243480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Infections in the oncologic patient. Prevention and treatment].
    Cubellos J
    An Esp Pediatr; 1988 Sep; 29 Suppl 33():178-81. PubMed ID: 3074699
    [No Abstract]   [Full Text] [Related]  

  • 15. Ustekinumab: cutaneous disorders, malignancies, infections.
    Prescrire Int; 2015 Jan; 24(156):17. PubMed ID: 25729825
    [No Abstract]   [Full Text] [Related]  

  • 16. [Linear IgA bullous dermatosis: a review].
    Ingen-Housz-Oro S
    Ann Dermatol Venereol; 2011 Mar; 138(3):214-20. PubMed ID: 21397151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in the treatment of autoimmune mucocutaneous blistering diseases.
    Ahmed AR
    Int J Periodontics Restorative Dent; 2007 Aug; 27(4):309-10. PubMed ID: 17726986
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening for infections prior to initiating immunosuppressive treatment for patients with autoimmune blistering diseases.
    Murrell DF
    Br J Dermatol; 2014 Dec; 171(6):1285-6. PubMed ID: 25523248
    [No Abstract]   [Full Text] [Related]  

  • 19. Transplant infectious disease: a work in progress.
    Rubin RH
    Transpl Infect Dis; 2005 Jun; 7(2):49-50. PubMed ID: 16150089
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunization in children and adolescents with rheumatic diseases].
    Minden K; Niewerth M; Borte M; Singendonk W; Haas JP
    Z Rheumatol; 2007 Mar; 66(2):111-2, 114-8, 120. PubMed ID: 17364157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.